ISSN: 2008-2258
Vol 12, No 3 (2019): Summer
Evaluation of gene expression change in eosinophilic gastroenteritis
Gastroenterology and Hepatology from Bed to Bench,
,
,
Page 239-245
https://doi.org/10.22037/ghfbb.v12i3.1635
Abstract
Aim: Screening differentially expressed genes (DEGs) related to Eosinophilic gastroenteritis (EG) to introduce possible biomarkers.
Background: EG as a rare gastrointestinal disorder is characterized with gastrointestinal bleeding, crampy generalized abdominal pain, diarrhea, nausea, vomiting, and weight loss. In this study gene expression profile of patients is analysis via protein-protein interaction (PPI) analysis to reveal new prospective of disease.
Methods: Top significant genes of gene expression profiles of 5 gastric antrum EG patients and 5gastric antrum control from GEO which were matched via boxplot analysis were screened via PPI network by using Cytoscape software and STRING database. Numbers of 20 top nodes of query DEGs based on degree value were introduced as central nodes which 7 critical central genes among them were identified. Gene ontology enrichment for the 20 central genes was done by using CluGO. Action map for the central genes was performed by applying CluePedia.
Results: Among 20 central nodes, TXN, PRDX2, NR3C1, GRB2, PIK3C3, AP2B1 and REPS1 were recognized as critical central genes. Nine biological terms were determined that most of them were involved in the transport processes.
Conclusion: The introduced possible biomarkers can be used in the differential diagnosis of the disease and also in treatment of disorder.
Keywords: Eosinophilic gastroenteritis, gene, protein-protein interaction network.
(Please cite as: Zadeh-Esmaeel MM, Rezaei-Tavirani M, Ahmadi NA, Vafaee R. Evaluation of gene expression change in eosinophilic gastroenteritis. Gastroenterol Hepatol Bed Bench 2019;12(3):239-245).
- Eosinophilic gastroenteritis
- gene
- protein
How to Cite
References
Müller M, Keller K, Stallmann S, Eckardt AJJJGSGT. Clinicopathologic Findings in Eosinophilic Gastroenteritis: A German Case Series. J Genet Syndr Gene Ther 2014;5:2.
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World J Gastroenterol 2013 21;19:5061-6.
Mansoor E, Saleh MA, Cooper GS. Prevalence of Eosinophilic Gastroenteritis and Colitis in a Population-Based Study, From 2012 to 2017. Clin Gastroenterol Hepatol 2017;15:1733-1741.
Abou Rached A, El Hajj W. Eosinophilic gastroenteritis: Approach to diagnosis and management. World J Gastrointest Pharmacol Ther 2016;7:513-23.
Keshavarzian A, Saverymuttu SH, Tai PC, Thompson M, Barter S, Spry CJ, Chadwick VS. Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 1985;88:1041-9.
Butterfield JH, Murray JA. Eosinophilic gastroenteritis and gluten-sensitive enteropathy in the same patient. J Clin Gastroenterol 2002;34:552-3.
Copeland BH, Aramide OO, Wehbe SA, Fitzgerald SM, Krishnaswamy G. Eosinophilia in a patient with cyclical vomiting: a case report. Clin Mol Allergy 2004;2:7.
Ciccia F, Giardina AR, Alessi N, Rodolico V, Galia M, Ferrante A, et al. Successful intravenous immunoglobulin treatment for steroid-resistant eosinophilic enteritis in a patient with systemic lupus erythematosus. Clin Exp Rheumatol 2011;29:1018-20.
Ingle SB, Patle YG, Murdeshwar HG, Pujari GP. A case of early eosinophilic gastroenteritis with dramatic response to steroids. J Crohns Colitis 2011;5:71-2.
Daneshjoo R, J Talley N. Eosinophilic gastroenteritis. Curr Gastroenterol Rep 2002;4:366-72.
Forbes E, Hulett M, Ahrens R, Wagner N, Smart V, Matthaei KI, et al. ICAM-1-dependent pathways regulate colonic eosinophilic inflammation. J Leukoc Biol 2006;80:330-41.
Jaffe JS, James SP, Mullins GE, Braun-Elwert L, Lubensky I, Metcalfe DD. Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol 1994;14:299-309.
Spergel JM, Aceves SS, Kliewer K, Gonsalves N, Chehade M, Wechsler JB, et al. New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting. J Allergy Clin Immunol 2018;142:48-53.
Mori A, Enweluzo C, Grier D, Badireddy M. Eosinophilic gastroenteritis: review of a rare and treatable disease of the gastrointestinal tract. Case Rep Gastroenterol 2013;7:293-8.
Brysbaert G, Mauri T, Lensink MF. Comparing protein structures with RINspector automation in Cytoscape. Version 2. F1000Res 2018;7:563.
Moradifard S, Hoseinbeyki M, Ganji SM, Minuchehr Z. Analysis of microRNA and gene expression profiles in Alzheimer’s disease: a meta-analysis approach. Scientific Rep 2018;8:4767.
Rezaei-Tavirani M, Hasanzadeh H, Seyyedi S, Ghoujeghi F, Semnani V, Zali H. Proteomic analysis of Extremely Low-Frequency ElectroMagnetic Field (ELF-EMF) with different intensities in rats hippocampus. Archives Neuroscience 2018;5.
Méndez-Sánchez N, Chávez-Tapia NC, Vazquez-Elizondo G, Uribe M. Eosinophilic gastroenteritis: a review. Dig Dis Sci 2007;52:2904-11.
Uppal V, Kreiger P, Kutsch E. Eosinophilic gastroenteritis and colitis: a comprehensive review. Clin Rev Allergy Immunol 2016;50:175-88.
Azodi MZ, Rezaei-Tavirani M, Nejad MR, Rezaei-Tavirani M. Human Prolactinoma: A View of Protein-Protein Interaction Pattern. Inter J Endocrinology Metabolism 2018;16.
Mansouri V, Tavirani SR, Zadeh-Esmaeel MM, Rostami-Nejad M, Rezaei-Tavirani M. Comparative study of gastric cancer and chronic gastritis via network analysis. Gastroenterol Hepatol Bed Bench 2018;11:343.
Lee W, Choi KS, Riddell J, Ip C, Ghosh D, Park JH, et al. Human Peroxiredoxin 1 and 2 are not duplicate proteins the unique presence of cys83 in prx1 underscores the structural and functional differences between prx1 and prx2. J Biol Chem 2007;282:22011-22.
Nagy P, Karton A, Betz A, Peskin AV, Pace P, O'Reilly RJ, et al. Model for the exceptional reactivity of peroxiredoxins 2 and 3 with hydrogen peroxide a kinetic and computational study. J Biol Chem 2011;286:18048-55.
Zhang Yy, Li X, Qian Sw, Guo L, Huang Hy, He Q, et al. Down-regulation of type I Runx2 mediated by dexamethasone is required for 3T3-L1 adipogenesis. Molecular Endocrinology 2012;26:798-808.
Lu H, Jiang T, Ren K, Li ZL, Ren J, Wu G, et al. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways. Cell Physiol Biochem 2018;49:217-25.
Yamazaki T, Zaal K, Hailey D, Presley J, Lippincott-Schwartz J, Samelson LE. Role of Grb2 in EGF-stimulated EGFR internalization. J Cell Sci 2002;115:1791-802.
Ingle SB, Hinge CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. WJG 2013;19:5061.
Perez-Millan A, Martin-Lorente JL, Lopez-Morante A, Yuguero L, Saez-Royuela F. Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate. Dig Dis Sci 1997;42:342-4.
Moots R, Prouse P, Gumpel J. Near fatal eosinophilic gastroenteritis responding to oral sodium chromoglycate. Gut 1988;29:1282-5.
Jullien-Flores V, Mahé Y, Mirey G, Leprince C, Meunier-Bisceuil B, Sorkin A, et al. RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis. J Cell Sci 2000;113:2837-44.
Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, et al. Bridging ral GTPase to Rho pathways RLIP76, a ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem 1995;270:22473-7.
- Abstract Viewed: 75 times
- PDF Downloaded: 67 times
